Learn More
Medchemexpress LLC PMX 205 Trifluoroacetate | 99.5% | 953.06 | 100 MG

Supplier: Medchemexpress LLC HY110136A100MG
PMX 205 Trifluoroacetate is identified as a specific complement C5aR1 isoform antagonist. It is intended for research use only and is not sold to patients.
- Specific complement C5aR1 isoform antagonist.
- Orally active, selective C5aR antagonist.
- Extends survival time and reduces end-stage motor scores in SOD1G93A rats.
- Reduces astroglial proliferation in the lumbar spinal cord.
- Decreases fibrillar plaque load in Tg2576 mice.
- Significantly reduces hyperphosphorylated tau in 3xTg mice.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.